SCHEMBL5331753

SCHEMBL5331753

CC(C)(C)OC(=O)n1cccc1-c1cccc2c1C(=O)NC2

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AURKA O14965 7/20 0.42
KDR P35968 7/20 0.42
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
PIK3R1 P27986 1/20 0.40
PIK3CA P42336 1/20 0.40
BUB1 O43683 1/20 0.40
CDK1 P06493 1/20 0.38
MAPK1 P28482 1/20 0.37
GPR119 Q8TDV5 2/20 0.36
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
PDK4 Q16654 1/20 0.35
TNK2 Q07912 1/20 0.35
PARP1 P09874 1/20 0.35
PIM1 P11309 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
BRD4 O60885 1/20 0.34
CREBBP Q92793 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5332117 0.81 PARP1 (0.45) HSP90AA1HSP90AB1PIK3R1PIK3CABUB1
SCHEMBL5330620 0.78 BRD4 (0.55) CA12CA9BRD4CREBBP
SCHEMBL22036737 0.77 HSP90AA1 (0.53) HSP90AA1HSP90AB1PIK3R1PIK3CABUB1
SCHEMBL5327530 0.75 AURKA (0.48) AURKAKDRCDK1CA12CA9
SCHEMBL5333314 0.74 KDR (0.52) AURKAKDRCA12CA9PIM1
SCHEMBL18812369 0.72 HSP90AA1 (0.49) HSP90AA1HSP90AB1PIK3R1PIK3CABUB1
SCHEMBL24697208 0.71 HSP90AA1 (0.48) HSP90AA1HSP90AB1PIK3R1PIK3CABUB1
SCHEMBL26819799 0.71 PIK3R1 (0.54) HSP90AA1HSP90AB1PIK3R1PIK3CABUB1
SCHEMBL31283508 0.71 BUB1 (0.44) HSP90AA1HSP90AB1BUB1MAPK1GPR119
SCHEMBL15417099 0.71 HSP90AA1 (0.53) HSP90AA1HSP90AB1PIK3R1PIK3CABUB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070161648-A1 Substituted dihydro-isoindolones useful in treating kinase disorders JANSSEN PHARMACEUTICA, N.V. (BE) 2007-07-12 US claimed
WO-2007047646-A2 SUBSTITUTED DIHYDRO-ISOINDOLONES USEFUL IN TREATING KINASE DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-04-26 WO claimed
US-20070161648-A1 Substituted dihydro-isoindolones useful in treating kinase disorders JANSSEN PHARMACEUTICA, N.V. (BE) 2007-07-12 US disclosed
US-20070161648-A1 Substituted dihydro-isoindolones useful in treating kinase disorders JANSSEN PHARMACEUTICA, N.V. (BE) 2007-07-12 US disclosed
US-20070161648-A1 Substituted dihydro-isoindolones useful in treating kinase disorders JANSSEN PHARMACEUTICA, N.V. (BE) 2007-07-12 US disclosed
WO-2007047646-A2 SUBSTITUTED DIHYDRO-ISOINDOLONES USEFUL IN TREATING KINASE DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-04-26 WO disclosed
WO-2007047646-A2 SUBSTITUTED DIHYDRO-ISOINDOLONES USEFUL IN TREATING KINASE DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161648-A1 Substituted dihydro-isoindolones useful in treating kinase disorders MAP3K20, MAP3K3, MAP3K19 AURKA 669/4885KDR 1627/4885HSP90AA1 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.